Nutritional assessment and support of the patient with acute heart failure

Current Opinion in Critical Care

Volumn 16, Issue 5, 2010, Pages 413-418

  Sarma, Satyam ^a   Gheorghiade, Mihai ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cardiac cachexia; Carnitine; Nutrition in heart failure; Omega 3 fatty acids; Thiamine

Indexed keywords

OMEGA 3 FATTY ACID;

ACUTE HEART FAILURE; CACHEXIA; DIET SUPPLEMENTATION; FOOD INTAKE; HOSPITALIZATION; HUMAN; MORBIDITY; MORTALITY; NUTRITIONAL ASSESSMENT; NUTRITIONAL SUPPORT; PATIENT CARE; REVIEW; VITAMIN D DEFICIENCY;

HEART FAILURE; HUMANS; INTENSIVE CARE; NUTRITION ASSESSMENT; NUTRITIONAL SUPPORT;

EID: 78449286921     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32833e10d4     Document Type: Review

References (43)

1. Carr JG, Stevenson LW, Walden JA, Heber D. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1989; 63:709-713.
2. Aquilani R, Opasich C, Verri M, et al. Is nutritional intake adequate in chronic heart failure patients? J Am Coll Cardiol 2003; 42:1218-1223.
3. Grossniklaus DA, O'Brien MC, Clark PC, Dunbar SB. Nutrient intake in heart failure patients. J Cardiovasc Nurs 2008; 23:357-363.
4. Horwich TB, Kalantar-Zadeh K, MacLellan RW, et al. Albumin levels predict survival in patients with systolic heart failure. Am Heart J 2008; 155:883-889.
5. Opasich C, Aquilani R, Dossena M, et al. Biochemical analysis of muscle biopsy in overnight fasting patients with severe chronic heart failure. Eur Heart J 1996; 17:1686-1693.
6. Ingwall JS. ATP and the heart. Boston, MA: Kluwer Academic; 2002:; p. 16.
7. Pannunzio P, Hazell AS, Pannunzio M, et al. Thiamine deficiency results in metabolic acidosis and energy failure in cerebellar granule cells: an in vitro model for the study of cell death mechanisms in Wernicke's encephalopathy. J Neurosci Res 2000; 62:286-292.
8. Dobrin JS, Lebeche D. Diabetic cardiomyopathy: signaling defects and therapeutic approaches. Expert Rev Cardiovasc Ther 2010; 8:373-391.
9. Ingwall JS. On the hypothesis that the failing heart is energy starved: lessons learned from the metabolism of ATP and creatine. Curr Hypertens Rep 2006; 8:457-464; Review.
10. Levitan EB, Wolk A, Mittleman MA. Consistency with the DASH diet and incidence of heart failure. Arch Intern Med 2009; 169:851-857.
11. Catapano G, Pedone C, Nunziata E, et al. Nutrient intake and serum cytokine pattern in elderly people with heart failure. Eur J Heart Fail 2008; 10:428-434.
12. Broqvist M, Arnqvist H, Dahlstrom U, et al. Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure-effects of long-term dietary supplementation. Eur Heart J 1994; 15:1641-1650.
13. Gorelik O, Almoznino-Sarafian D, Feder I, et al. Dietary intake of various nutrients in older patients with congestive heart failure. Cardiology 2003; 99:177-181.
14. Arcand J, Floras V, Ahmed M, et al. Nutritional inadequacies in patients with stable heart failure. J Am Diet Assoc 2009; 109:1909-1913.
15. Reyes AJ, Leary WP. Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations. Cardiovasc Drugs Ther 1993; 7 (Suppl 1):29-44.
16. Cody RJ, Kubo SH, Pickworth KK. Diuretic treatment for the sodium retention of congestive heart failure. Arch Intern Med 1994; 154:1905-1914.
17. Gottlieb SS, Baruch L, Kukin ML, et al. Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J Am Coll Cardiol 1990; 16:827-831.
18. Hanninen S, Darling P, Sole M, et al. The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure. J Am Coll Cardiol 2006; 47:354-361.
19. Keith ME, Walsh NA, Darling PB, et al. B-vitamin deficiency in hospitalized patients with heart failure. J Am Diet Assoc 2009; 109:1406-1410.
20. Talwar D, Davidson H, Cooney J, St. Jo'Reilly D. Vitamin B1 status assessed by direct measurement of thiamin pyrophosphate in erythrocytes or whole blood by HPLC: comparison with erythrocyte transketolase activation assay. Clin Chem 2000; 46:704-710.
21. Hardig L, Daae C, Dellborg M, et al. Reduced thiamine pyrophosphate, but not thiamine diphosphate, in erythrocytes in elderly patients with congestive heart failure treated with furosemide. J Intern Med 2000; 247:597-600.
22. Soukoulis V, Dihu JB, Sole M, et al. Micronutrient deficiencies an unmet need in heart failure. J Am Coll Cardiol 2009; 54:1660-1673.
23. Witte KK, Nikitin NP, Parker AC, et al. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 2005; 26:2238-2244.
24. Seligmann H, Halkin H, Rauchfleisch S, et al. Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. Am J Med 1991; 91:151-155.
25. Shimon I, Almog S, Vered Z, et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med 1995; 98:485-490.
26. Smithline HA. Thiamine for the treatment of acute decompensated heart failure. Am J Emerg Med 2007; 25:124-126.
27. Arsenian MA. Carnitine and its derivatives in cardiovascular disease. Prog Cardiovasc Dis 1997; 40:265-286.
28. Mancini M, Rengo F, Lingetti M, et al. Controlled study on the therapeutic efficacy of propionyl-L-carnitine in patients with congestive heart failure. Arzneimittelforschung 1992; 42:1101-1104.
29. Iliceto S, Scrutinio D, Bruzzi P, et al. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) trial. J Am Coll Cardiol 1995; 26:380-387.
30. Rizos I. Three-year survival of patients with heart failure caused by dilated cardiomyopathyand L-carnitine administration. Am HeartJ 2000; 139:S120-S123.
31. Investigators Gissi-HF, Tavazzi L, Maggioni AP, et al. Effect of n-3 polyunsa-turated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008; 372:1223-1230.
32. Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 2009; 54:585-594.
33. Kim DH, Sabour S, Sagar UN, et al. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 2008; 102:1540-1544.
34. Nemerovski CW, Dorsch MP, Simpson RU, et al. Vitamin D and cardiovascular disease. Pharmacotherapy 2009; 29:691-708.
35. Berger MM, Chiolero RL. Enteral nutrition and cardiovascular failure: from myths to clinical practice. JPEN J Parenter Enteral Nutr 2009; 33:702-709.
36. Khalid I, Doshi P, DiGiovine B. Early enteral nutrition and outcomes of critically ill patients treated with vasopressors and mechanical ventilation. Am J Crit Care 2010; 19:261-268.
37. Von Haehling S, Lainscaka M, Springera J, Anker SD. Cardiac cachexia: a systematic overview. Pharmacol Ther 2009; 121:227-252.
38. Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997; 349:1050-1053.
39. Anker SD, Coats AJS. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 1999; 115:836-847.
40. Chung ES, Packer M, Lo KH, et al., for the Anti-TNF Therapy Against Congestive Heart Failure Investigators. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heartfailure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 2003; 107:3133-3140.
41. Mann DL, McMurray JJ, Packer M, et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 2004; 109:1594-1602.
42. Kung T, Springer J, Doehner W, et al. Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference. Expert Opin Investig Drugs 2010; 19:579-585.
43. Harinstein ME, Berliner JI, Shah SJ, et al. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients. Am J Ther 2008; 15: 206-213.